Prof. Dr. Yavuz Aydın

Bilimsel Yayınlar

Bibliyografik kayıtlar özgün dilinde sunulmuştur.

Bilimsel dergilerdeki makaleler

1. Bladder exstrophy. Uludag S, Guralp O, Akbas M, Aydin Y, Sen C, Uludag S. Fetal Pediatr Pathol. 2012 Aug;31(4):225-9. doi: 10.3109/15513815.2011.650286. Epub 2012 Mar 20. PMID: 22432588
2. PAPP-A concentrations change in patients with gestational diabetes. Caliskan R, Atis A, Aydin Y, Acar D, Kiyak H, Topbas F. J Obstet Gynaecol. 2020 Feb;40(2):190-194. doi: 10.1080/01443615.2019.1615041. Epub 2019 Jul 23. PMID: 31335241
3. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H. Acta Obstet Gynecol Scand. 2013 Dec;92(12):1369-74. doi: 10.1111/aogs.12247. Epub 2013 Oct 15. PMID: 23980726
4. Remission of endometriosis by hyperbaric oxygen treatment in rats. Aydin Y, Atis A, Uludag S, Tezer I, Sakiz D, Acar H, Toklu A. Reprod Sci. 2011 Oct;18(10):941-7. doi: 10.1177/1933719111400635. PMID: 21960508
5. Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovaries. Atis A, Aydin Y, Ciftci F, Sakız D, Arslan A, Toklu AS, Donmez M, Goker N. Reprod Biol Endocrinol. 2012 Feb 6;10:11. doi: 10.1186/1477-7827-10-11. PMID: 22309835
6. Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms. Sahmay S, Aydin Y, Oncul M, Senturk LM. J Assist Reprod Genet. 2014 Feb;31(2):213-20. doi: 10.1007/s10815-013-0149-0. Epub 2013 Dec 18. PMID: 24343036
7. Multiple fetal anomalies in association with topiramate and oxcarbezepine treatment. Uludag S, Aydin Y, Yilmaz O, Aksoy F, Bakkaloglu D, Sen C. Fetal Pediatr Pathol. 2012 Jun;31(3):154-8. doi: 10.3109/15513815.2012.659378. Epub 2012 Mar 13. PMID: 22413958
8. Is endometrial apoptosis evidence of endometrial aging in unexplained infertility? a preliminary report. Erel CT, Aydin Y, Kaleli S, Ilvan S, Senturk LM. Eur J Obstet Gynecol Reprod Biol. 2005 Aug 1;121(2):195-201. doi: 10.1016/j.ejogrb.2005.01.012. PMID: 16054962
9. Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology. Sahmay S, Aydın Y, Atakul N, Aydogan B, Kaleli S. Gynecol Endocrinol. 2014 Feb;30(2):130-4. doi: 10.3109/09513590.2013.867320. Epub 2013 Dec 16. PMID: 24328568
10. Late pregnancy associated plasma protein A levels decrease in preterm labor. Atis A, Tandogan T, Aydin Y, Sen C, Turgay F, Eren N, Goker N. J Matern Fetal Neonatal Med. 2011 Jul;24(7):923-7. doi: 10.3109/14767058.2010.531320. Epub 2011 May 11. PMID: 21557695
11. Hereditary thrombophilia, anti-beta2 glycoprotein 1 IgM, and anti-annexin V antibodies in recurrent pregnancy loss. Karata S, Aydin Y, Ocer F, Buyru A, Balci H. Am J Reprod Immunol. 2012 Mar;67(3):251-5. doi: 10.1111/j.1600-0897.2011.01092.x. Epub 2011 Nov 22. PMID: 22103678
12. PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome. Atis A, Aydin Y, Basol E, Kaleli S, Turgay F, Goker N. Arch Gynecol Obstet. 2012 Jan;285(1):45-9. doi: 10.1007/s00404-011-1912-z. Epub 2011 Apr 30. PMID: 21533533
13. Comparison of complications in second trimester amniocentesis performed with 20G, 21G and 22G needles. Uludag S, Aydin Y, Ibrahimova F, Madazli R, Sen C. J Perinat Med. 2010 Nov;38(6):597-600. doi: 10.1515/jpm.2010.105. Epub 2010 Aug 13. PMID: 20707629
14. Effects of amniotic and maternal CD-146, TGF-β1, IL-12, IL-18 and IFN-γ, on adverse pregnancy outcome. Cift T, Uludag S, Aydin Y, Benian A. J Matern Fetal Neonatal Med. 2013 Jan;26(1):21-5. doi: 10.3109/14767058.2012.722712. Epub 2012 Sep 11. PMID: 22913276
15. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer. Balcan E, Demirkiran F, Aydin Y, Sanioglu C, Bese T, Arvas M, Akçay T, Cift T. Int J Gynecol Cancer. 2012 Sep;22(7):1138-42. doi: 10.1097/IGC.0b013e31825b7dcc. PMID: 22914212

Kaynaklar: Medical Park · PubMed